Number of Shares
216,500.00
Current Holdings Value*
$7.37 Mil
% of Portfolio
4.95%
Total Estimate Gain
$3.47 Mil
% of Total Estimate Gain
17.35%

American Beacon ARK Transformational Innovation Fund's CRISPR Therapeutics AG Holding Summary

As of 2025-03-31, AMERICAN BEACON FUNDS held 216,500.00 shares of CRISPR Therapeutics AG(CRSP), totaling $7.37 Mil. This investment constitutes 4.95% of their stock portfolio, and AMERICAN BEACON FUNDS now holds 0.25% of the outstanding CRISPR Therapeutics AG(CRSP) stock.

The initial trade took place in 2019Q3. And since then American Beacon ARK Transformational Innovation Fund has made 8 purchases of CRSP, at an average price of $55.74, for a total of 358,572.00 shares. In addition, there have been 9 sales at an average price of $73.52 for 142,072.00 shares. Based on historical transaction data and CRSP's current price of $60.08, American Beacon ARK Transformational Innovation Fund's estimated gain on his CRSP holdings is $3.47 Mil, reflecting a 17.35% gain to date.

American Beacon ARK Transformational Innovation Fund CRSP ($60.08) Holding Chart

American Beacon ARK Transformational Innovation Fund CRSP ($60.08) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1